By Deb Hetherington, Director of Innovation Ecosystems
In healthcare, innovation is often seen as a flash of individual brilliance, a new piece of technology, a research breakthrough, or a clever spin-out. But in reality, innovation rarely happens in isolation. It thrives in the right conditions, with the right people, and in the right places.
That’s why the concept of innovation ecosystems has become central to how we think about progress in health and life sciences. It’s not just about generating good ideas, but about creating environments where those ideas can be tested, shaped, implemented, and scaled.
In this article, our Director of Innovation Ecosystems, Deb Hetherington, shares her insights on why ecosystems matter, and how they’re shaping the future of health and life sciences.
An innovation ecosystem is more than a loose collection of organisations. It’s a deliberately-designed mix of space, networks, partnerships, culture, and intent that supports the full journey from early-stage concept to real-world implementation, and crucially to scale.
In healthcare, this means bringing together universities, NHS trusts, startups, SMEs, corporates, investors, and policy-makers in shared environments where collaboration isn’t an aspiration, it’s the expectation. Ecosystems like these enable ideas to move from bench to bedside more quickly and more effectively. They improve patient care, accelerate time to market, and create commercial value through coordination and strategic alignment.
Place-making plays a pivotal role in how innovation happens. Not all workspaces are equal. Research shows that purpose-built innovation districts can be up to 20 percent more productive than generic city-centre offices. But it’s not just about productivity.
When environments are designed specifically to support innovation, they enable connection. Informal conversations in shared corridors or cafés often spark partnerships that formal meetings can’t. Access to specialist facilities such as wet labs, prototyping space, and clinical testing environments removes friction for those trying to move quickly. And by attracting mission-aligned organisations, these spaces build a culture where collaboration is normal, not exceptional.
Innovation doesn’t just need a roof over its head. It needs a framework that supports exploration, risk taking, and commercialisation.
One of the most effective frameworks for innovation is the triple helix model, where academia, industry, and the public sector work in close alignment. Each brings something essential. Universities offer research expertise and access to knowledge infrastructure. Industry brings commercial insight, investment, and often the practical drive to scale innovation. And within the NHS, clinicians, surgeons, and frontline staff are frequently the originators of new ideas, grounded in real-world challenges and patient needs.
When these forces align, ecosystems gain momentum. Innovation is no longer siloed or accidental, it becomes focused, accelerated, and grounded in purpose. Co-creation replaces handoff. Problems are identified by those who live them, and solutions are developed through shared effort. This shift builds trust, makes adoption more likely, and helps ensure investment is directed where it matters most.
Purpose-built environments make this kind of collaboration possible. When people with different expertise are brought together, across sectors, disciplines, and organisations, the barriers between idea, application, and impact begin to dissolve.
Around the world, we’re seeing how well-structured innovation ecosystems can deliver real results. In Toronto, the MaRS Discovery District brings clinicians and entrepreneurs together in a 1.5 million square foot centre in the heart of the city. It’s not just a building, but a carefully designed environment where collaboration is built into the fabric of the space and patient outcomes stay at the centre of innovation.
In Oslo, Science City is redefining how health innovation ecosystems function. Through strategic partnerships between global pharmaceutical firms, local start-ups, and research institutions, shared tenancy and joint programme design have created a highly commercial, collaborative environment. You can read more in our feature, Innovation Beyond Borders: Lessons from Oslo. Similarly, the Amsterdam Life Sciences District demonstrates how long-term joint ventures between academia and the private sector can embed innovation throughout both research and delivery.
These places succeed not just because of their infrastructure, but because of their clarity of purpose, alignment of partners, and openness to experimentation.
Here in the UK, cities like Leeds and Sheffield are building something just as ambitious, and we’re proud to be playing a role in it. In Leeds, we’re working with Leeds Teaching Hospitals NHS Trust, Leeds Beckett University, Nexus, Leeds City Council, and the West Yorkshire Combined Authority to bring the vision for the Old Medical School to life. The goal is to create a purpose-built health innovation centre that acts as a physical and cultural hub for collaboration, commercialisation, and improved patient outcomes.
At Sheffield Olympic Legacy Park, we’re doing the same, partnering with Sheffield City Council, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield Children’s NHS Foundation Trust, Sheffield Hallam University, NHS South Yorkshire Integrated Care Board, Health Innovation Yorkshire & Humber, and the South Yorkshire Mayoral Combined Authority. Together, we’re creating a space where health, wellbeing, sport, and innovation meet, designed not only to inspire new ideas, but to accelerate them into practice.
These are not isolated developments. They are part of a broader, regional movement to turn bold ambitions into shared impact, using place as a catalyst for progress.
A key difference between high-functioning ecosystems and traditional commercial developments is the role of the ecosystem manager. Leasing space is not enough. Supporting innovation means understanding where an organisation is, where it wants to go, and what’s standing in its way. That’s why we start with diagnostic assessments, tailored conversations that surface opportunities, gaps, and needs.
From there, our role is one of curation. Many of the programmes, networks, and funding opportunities already exist. We don’t reinvent what’s working. We connect people to what is relevant. And where we identify gaps, we step in to create new partnerships, interventions, or activities to fill them.
This brokered model helps businesses move faster, reduces duplication, and keeps intellectual property, talent, and commercial value rooted in the region, benefiting both the organisations involved and the wider ecosystem around them.
Health innovation is about more than solving clinical problems. It drives growth, resilience, and long-term value. It creates confidence for investors, opportunity for researchers, better experiences for patients, and economic vitality for cities.
But most of all, it creates the conditions where innovation becomes routine, not rare. Where collaboration is expected, not exceptional.
Collaboration is the child of innovation. But collaboration doesn’t happen by accident. It happens in places built to support it.
